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Objective: We review our experience with Fontan conversion and cryoablation in
patients with an atriopulmonary Fontan in low cardiac output from arrhythmia or
venous obstruction, including 2 patients with protein-losing enteropathy.
Methods: Ten patients (mean age 21.1  7.0 years) underwent extracardiac Fontan
conversion, cryoablation, and pacemaker placement between November 1999 and
April 2002 (13.1  4.1 years after the original atriopulmonary connection). Eight
patients were in New York Heart Association class III and 2 were in New York
Heart Association class IV. Nine patients had clinically important intra-atrial reentry
tachycardia refractory to medical therapy.
Results: Follow-up was between 3.1 and 32.6 months (16.8  9). One death
occurred at 7 days after surgery due to sepsis and multisystem organ failure. The
second death occurred at 48 days from complications of protein-losing enteropathy.
The second patient with protein-losing enteropathy had improved New York Heart
Association classification, cessation of albumin transfusions, and a normal stool
alpha antitrypsin level (down from 4.1 mg/g preoperatively). Five patients improved
to New York Heart Association class I and 3 patients to New York Heart Associ-
ation class II. Sustained arrhythmias could not be induced in any patient. Seven
patients are on no antiarrhythmics. One patient had recurrence of intra-atrial
reentrant tachycardia 11 months postoperatively, which required electrical cardio-
version; this patient’s symptoms are currently well controlled on 1 medication.
Conclusion: Extracardiac Fontan, cryoablation, and pacemaker placement reduced
atrial arrhythmias and improved New York Heart Association classification in all
surviving patients. In selected patients, this operation offers improvement in clinical
outcome and is an alternative to transplantation. Protein-losing enteropathy may not
be a contraindication to performing Fontan conversion with cryoablation.
Since the first successful atriopulmonary connection (APC) was re-ported by Fontan in 1971, the Fontan procedure has been applied topalliate multiple forms of functional single ventricle.1 Long-termsequelae of an atriopulmonary Fontan have been well described andinclude intra-atrial reentrant tachycardia (IART), pulmonary and sys-temic venous obstruction, thromboembolism, protein-losing enterop-
athy (PLE), and decreased cardiac output.2-6
The increased right atrial flow and suture load that these patients experience from
the time of the original Fontan have been felt to be one cause of their atrial
arrhythmias. The arrhythmias can further increase right atrial pressure, which leads
to a negative cycle that leads to considerable morbidity and mortality.2,3,7 Atrial
arrhythmias have been reported between 22% and 50% of patients with an APC
Fontan.2,3,7 PLE is seen in between 3.7% and 10% of patients but has very high rates
of morbidity and mortality.2,5 The mortality rate within 5 years of the diagnosis of
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PLE is 40%.5 Although not always clinically apparent, atrial
thrombus was reported in 33% of patients having undergone
a variety of different Fontan-type operations.6
Total cavopulmonary connection (TCPC) has been one
of the modifications to the Fontan operation suggested to
improve atrial flow characteristics and hopefully avoid right
atrial distention, arrhythmia, and the other long-term se-
quelae seen with APCs.8,9 This adjustment and other mod-
ifications, such as fenestration and modified ultrafiltration,
have decreased the morbidity and mortality rates from a
Fontan operation in the current era, but more time will be
needed to evaluate the long-term complications of the
TCPC Fontan operation.5,10-13
Conversion of an atriopulmonary Fontan to a lateral tunnel
or extracardiac Fontan has been attempted to alleviate compli-
cations by improving central systemic flow patterns. Many
authors hoped that lowering central venous pressure would
reduce atrial distention and decrease the presence of atrial
arrhythmias.14-16 In recent reviews of patients undergoing Fon-
tan revision by conversion to an extracardiac tunnel, half of the
patients received no relief from their arrhythmia or had a new
arrhythmia develop after the revision surgery.14-16 Kreutzer
and colleagues,16 reviewing the Boston experience, reported
on 8 patients undergoing conversion of a modified Fontan to
a lateral atrial tunnel Fontan. Two of the 8 patients had PLE,
defined in this study as a serum albumin concentration less
then 2 g/dL with a requirement for albumin replacement at
least once every 3 months. Four of 6 patients with an
arrhythmia preoperatively still had intra-atrial reentrant
tachycardia postoperatively. Additionally, neither of the 2
patients in this study with PLE undergoing Fontan revision
had improvement of this condition.16
Mavroudis and associates have demonstrated that revi-
sion of an APC Fontan, with the addition of cryoablation of
the foci of the IART, has markedly improved the outcome
for these patients.17-20 With a combination of preoperative
and intraoperative mapping, Deal and colleagues20 have
identified the anatomic circuits responsible for the atrial
arrhythmias in this cohort of patients. In their most recent
report of 40 patients undergoing total cavopulmonary con-
version, atrial cryoablation, and permanent pacemaker
placement for failed atriopulmonary Fontans, arrhythmia
recurrence was only 12.5%.17 Right atrial cryoablation was
performed in all patients for atrial flutter. Those patients
with atrial fibrillation also received left atrial cryoablation,
or a Cox maze III procedure. Only 10% of the patients
received long-term antiarrhythmic medications postopera-
tively, and 85% of the patients were in New York Heart
Association (NYHA) class I or II after the procedure.17
Like other institutions, we have struggled with the ap-
proach to treating patients with APC Fontans who are
symptomatic with IART. We applied Mavroudis’ and
Deal’s approach in our population and we review our ex-
perience, which includes 8 patients with intractable IART, 2
with systemic venous obstruction, 2 patients with PLE, and
all with poor NYHA classification.
Patients and Materials
Between November, 1999, and May, 2002, 10 patients (3 men, 7
women) underwent cryoablation and conversion of an APC to an
extracardiac Fontan. The age at reoperation was between 12.2 and
32.6 years (21.1  7.0 years) and the interval between original
APC to conversion was between 8.7 and 20.9 years (13.1  4.1
years). The initial Fontan was performed between the ages of 1.3
and 20.8 years (8.3  6.4 years). Four patients had a modified
Bjo¨rk procedure, 3 had a bidirectional Glenn shunt with an atrio-
pulmonary anastomosis, 1 had an atriopulmonary anastomosis
with a classic Glenn shunt, and 2 had only a right atrial–pulmonary
artery conduit (see Table 1). Two patients were formally evaluated
for cardiac transplantation but considered poor candidates due to
compliance and social issues.
Our current indications for conversion include deteriorating
NYHA classification, medically refractory IART, and evidence of
systemic venous obstruction. Although we would consider pulmo-
nary venous obstruction an indication, there were no patients with
pulmonary venous obstruction presenting in this series. Eight
patients were receiving multiple antiarrhythmic agents including
various combinations of digoxin, atenolol, sotalol, and amioda-
rone. Four patients had preoperative electrophysiologic testing and
3 underwent unsuccessful radiofrequency ablation. Six patients
required electrical cardioversion up to a maximum of 3 times.
Eight patients were in NYHA class III and two were in NYHA
class IV. All patients were dyspneic on exertion and had consid-
erable fatigue with minimal exercise.
One patient had a history of thromboembolic events and while
awaiting the procedure on the elective schedule was admitted
urgently for surgery secondary to a pulmonary embolus. Two
patients had a hemodynamically significant systemic venous ob-
struction, and 1 patient was cyanotic. All patients underwent
catheterization before the operation, and their hemodynamic and
oxygen saturation data are represented in Table 2.
Two patients carried a diagnosis of PLE preoperatively. One was
a 32-year-old man with tricuspid atresia in whom PLE was diagnosed
1 year after his original Fontan (16 years before his revision surgery.)
He received albumin and intravenous gamma globulin therapy every
3 to 4 months and had a stool alpha antitrypsin level of 69.9 mg/g. He
was treated chronically with steroids and heparin with limited im-
provement but was also a noncompliant patient. Frequent infections
and cellulitis caused him to be admitted to the hospital several times
a year. The second patient with PLE was a 13-year-old girl with
pulmonary atresia and intact ventricular septum whose diagnosis was
also reached within 1 year of her original Fontan (6 years before her
revision). After steroid therapy, her admissions to the hospital for
intravenous albumin and gamma globulin decreased from 4 times a
year to once a year. Her preoperative stool alpha antitrypsin level was
4.1 mg/g.
Operative and Cryoablation Procedure
The surgical technique applied was similar to that described by
Mavroudis and colleagues17-19 from Children’s Memorial Hospital
in Chicago.
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All patients were converted to an extracardiac Fontan (ECF).
The conduct for the creation of the TCPC was dictated by the
previous atriopulmonary or cavopulmonary connection. Three pa-
tients with a bidirectional Glenn shunt had the addition of an
extracardiac polytetrafluoroethylene (PTFE) tube graft to the right
pulmonary artery, while patients with only an APC underwent both
a bidirectional Glenn shunt and an ECF. One patient with a classic
Glenn shunt had continuity restored between the right and left
pulmonary arteries with homograft tissue before the placement of
an extracardiac tube graft from the inferior vena cava (IVC) to the
right pulmonary artery. Another patient had both a left and right
superior vena cava and both a left and right IVC. This patient
underwent bilateral bidirectional Glenn shunts and had an ECF
created via a PTFE tube graft to the right pulmonary artery from a
constructed confluence of the right and left IVC of autologous
atrial tissue.
All ECFs were performed with PTFE grafts of size 20 to 24,
and none were fenestrated. Resternotomy with standard technique
was performed in all patients. Femoral vessels were dissected
electively in 3 patients before resternotomy, and 2 of these patients
were placed on groin bypass urgently due to falling saturations and
blood pressure during sternal dissection. Once normothermic by-
pass was instituted the heart was kept beating until all of the
relevant vessels for reconstruction were visualized.
Patients underwent transesophageal echocardiography preoper-
atively, and an intraoperative bubble study was performed to
TABLE 1. Patient demographics
Patient Diagnosis
Age at
Fontan (y)
Interval to
redo (y)
Age at
redo (y) Indication Outcome
1 Tricuspid atresia
VSD
6.8 11.3 18.1 NHYA III NYHA I
2 Tricuspid atresia 3.7 16.1 19.7 NYHA III atrial
fib/flutter
NYHA II
nonsustained
IART
3 Pulmonary atresia
Intact ventricular
septum
4.5 9.3 13.8 NYHA III atrial
flutter
NYHA II
noninducible
IART
4 Tricuspid atresia
VSD
3.5 8.5 12.0 NYHA IV atrial
flutter PLE
NYHA I
noninducible
IART
5 Tricuspid atresia 20.9 11.4 32.3 NYHA III SVT
NOS
NYHA II
nonsustained
IART
6 DILV
Subaortic
chamber
noninducible
IART
16.7 11.0 27.7 NYHA III atrial
flutter
NYHA I
Left AV valve
atresia
Malposed great
arteries
7 Tricuspid atresia 5.1 12.0 17.1 NYHA III atrial
fib/flutter
PLE
Death
8 L-TGA
Right AV valve
atresia
VSD
12.8 18.0 30.8 NYHA III atrial
fib/flutter
Death
Pulmonary
stenosis
9 Tricuspid atresia 1.5 19.9 21.4 NYHA III
systemic
venous
obstruction
NYHA I
noninducible
IART
10 Tricuspid atresia
VSD
7.9 9.8 17.7 NYHA III atrial
flutter
NYHA I EP testing
pending
VSD, Ventricular septal defect; DILV, double-inlet left ventricle; L-TGA, levo-transposition of the great arteries; AV, atrioventricular; NYHA, New York Heart
Association; PLE, protein-losing enteropathy; SVT, supraventricular tachycardia; NOS, nitric oxide synthase; EP, electrophysiologic.
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confirm the absence or presence of an atrial septal defect. All
patients had right atrial cryoablation performed, although only the
2 patients with atrial fibrillation documented preoperatively re-
ceived left atrial cryoablation. In an attempt to minimize cardiac
ischemic time, patients whose atrial septum was intact underwent
cryoablation within the right atrium with the heart beating. After
placement of cryoablative lesions, patients were cooled to 28°C
and the heart was arrested. An atrial septectomy was then per-
formed, and a considerable amount of atrial tissue was excised
before atriotomy closure to markedly reduce atrial cavity size.
Previous right atrial suture lines, as in a Bjo¨rk modification, were
excised when not included within the cryoablation lines. After
atrial closure, all hearts were reperfused and the specific type of
Fontan revision for that patient was carried out with the heart
beating and patient rewarming.
The right atrial cryoablation lesions were placed in 4 distinct
locations as described by Mavroudis and colleagues19: (1) between
the posterior rim of the atrial septal defect to the posterior edge or
resected atrial wall; (2) between the superior aspect of the ASD
and the area of resected right atrial appendage; (3) from the IVC to
the rim of the coronary sinus os; and (4) from the IVC to the
annulus of the right-sided atrioventricular valve (Figure 1).
Two patients with atrial fibrillation underwent cryoablation in
the left atrium. Left atrial cryoablation was performed in the
arrested heart before atrial closure. These lesions were placed as
follows: (1) encircling the pulmonary veins, (2) from the pulmo-
nary veins toward the mitral valve annulus, and (3) at the orifice of
the left atrial appendage (Figure 2).
Lesions were laid down for 90 seconds at 60°C. A 15-mm
flat-faced Cooper surgical probe was used for the initial patients in
our series, but subsequently our approach changed to the use of 2
linear probes for greater efficiency (Figure 3). Intraoperative map-
ping was not performed.
Permanent DDD pacemakers were placed in all but 1 patient.
When possible, steroid-eluting epicardial leads were used; how-
ever, 1 patient received an active fixed helical lead due to poor
initial pacing thresholds on the ventricle. Two patients had their
atrial lead placed within the left atrium at the time of atrial
septectomy because of concern of the lack of availability of
surface atrial tissue. Programming of the pacemaker was individ-
ualized to the age of the patient. In all patients the lower rate was
set at 70 beats/min or higher to optimize cardiac output and
atrioventricular synchrony. The patient who did not receive a
permanent pacemaker had limited atrial tissue, poor initial sensi-
tivity and threshold values, and preserved sinus node function after
surgery. She has remained in sinus rhythm over 1 year after
surgery, and we have elected not to reoperate for a pacemaker.
Results
Data were obtained from patient charts and patient and
family member reports. All patients with a permanent pace-
maker underwent electrophysiologic study to assess induc-
ibility of postoperative intra-atrial reentrant tachycardia.
Mean follow-up was between 3.1 and 32.6 months (16.8
 9.5 months). There were 8 survivors and 2 deaths. All
survivors had improved NYHA classification. Of the 8
survivors, 5 patients are currently classified NYHA class I
and 3 are NYHA class II (Figure 4).
Mean cardiopulmonary bypass time in our cohort was
232  72 minutes and mean crossclamp time was 51  23
minutes. One patient underwent a brief period of circulatory
arrest of 14 minutes to improve visualization of the right
pulmonary artery due to a large amount of collateral flow.
Another patient required additional surgery to drain a se-
roma in a groin dissection site. One patient required revision
of a pacemaker generator site due to pectoralis muscle
stimulation. A second patient required reexploration for
postoperative bleeding from a pulmonary adhesion and was
extubated for 4 hours after surgery.
One patient died 7 days postoperatively of sepsis and
multisystem organ failure. This patient had a history of
mediastinitis with secondary healing of her sternum from
her original APC. Her conversion surgery was notable for a
lengthy dissection of her mediastinal adhesions, reconstruc-
tion of bilateral superior vena cava, bilateral IVC, and she
required reexploration for postoperative hemorrhage. On
postoperative day 4 she cultured positive for Staphylococ-
TABLE 2. Preoperative catheterization data
Patient
RA
(mm Hg)
PA
(mm Hg)
VEDP
(mm Hg)
Rp/Rs
(mm Hg) Qs Qp/Qs
O2 sat (%)
systemic
1 12 12 10 0.04 2.03 1.00 95
2 12 12 10 0.02 1.2 1.00 92
3 12 12 13 0.07 2.4 1.00 97
4 17 14 10 0.22 2.46 0.52 93
5 23 22 18 0.12 2.7 1.15 90
6 12 12 5 0.04 1.64 1.13 93
7 12 12 9 0.13 2.4 1.00 79
8 22 20 14 0.17 2.8 1.00 90
9 16 8 11 0.08 1.47 1.32 94
10 9 9 3 0.02 2.6 0.60 85
MeansSD 15.3 4.8 14.5 4.1 11.1 3.9 0.10 0.07 2.17 0.56 0.98 0.19 91.1 5.4
RAP, Right atrial pressure; PAP, pulmonary artery pressure; VEDP, ventricular end-diastolic pressure; Rp/Rs, pulmonary/systemic resistance ratio; Qs,
systemic blood flow; Qp/Qs, pulmonary/systemic blood flow ratio.
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cus aureus, as she did after her initial APC. The other
patient who died was 1 of the 2 patients in this series with
PLE. This patient showed significant improvement in his
cardiac output and IART control but continued to have
drainage of serous fluid from his mediastinal wound and
femoral vessel dissection site. He received multiple trans-
fusions of albumin and gamma globulin without clinical
improvement. Despite severe malnutrition he refused en-
teral or parenteral nutrition. At postoperative day 42 he was
readmitted to the hospital with malnutrition and sepsis. On
day 48 after surgery, he died of sepsis and multisystem
organ failure.
The other patient in our series with PLE has shown
remarkable improvement. Now 14 years old, she no longer
requires albumin transfusion therapy. Her last stool alpha
antitrypsin level was 2.6 mg/g, down from 4.1 mg/g preop-
eratively (normal  2.6 mg/g). Her exercise tolerance has
improved substantially. Wheelchair-bound preoperatively,
she now participates in school gym class. She is currently
undergoing a slow taper of steroids, which she continues to
use for arthritic symptoms.
IART was not present in any patient at the time of
discharge. Patients with permanent pacemakers underwent
electrophysiologic testing via their pacing system within 2
months of surgery to determine the inducibility of IART.
Standard pacing protocols using extrastimuli of singles,
doubles, and triples were applied. Four patients were not
inducible. Two patients had nonsustained atrial tachycardia
induced, defined as less than 1 minute. No patient has had a
significant atrial arrhythmia by clinical history.
One patient with giant atria, pulmonary embolism, and
atrial fibrillation/flutter has had no episodes of tachyarrhyth-
mia postoperatively for 1 year but recently had antiarrhyth-
mic therapy restarted with sotalol for paroxysmal episodes
of IART. This patient has had no further thromboembolic
events since surgery (24 months). His chest x-ray films
preoperatively and postoperatively represent the potential
nidus for thrombus formation and the substantial change
seen in atrial cavity size after atriectomy (Figure 5).
Discussion
For patients with deteriorating function after an APC Fon-
tan, the options include medical treatment, surgical revision,
or cardiac transplantation. Medical therapy for IART has a
high failure rate,21 and catheter-based radiofrequency abla-
tion often requires repeat interventions.22,23 Additionally,
these therapies do not address other potential sources of
decreased cardiac output such as giant right atrium and
systemic or pulmonary venous obstruction. Surgical revi-
sion of a Fontan alone, without cryoablation, addresses only
the anatomic pathology resulting in poor hemodynamics
and does not ablate the substrate for the reentrant arrhyth-
mias. Intra-atrial reentrant tachycardia is seen after surgical
revision of a Fontan without cryoablation, with its attendant
morbidity.4,14-16,24
There is considerable data suggesting that interruption of
IART with cryoablation in a failed Fontan, in addition to
right atrial reduction and conversion to an extracardiac
Figure 1. Lesions are placed in 4 locations at 60°C for 90
seconds each. In this patient with severe tricuspid stenosis a
linear cryoprobe is used to ablate tissue between the ASD and
the superior vena cava, the ASD and the lateral edge of the
atriotomy, the coronary sinus os and the cut edge of the IVC, and
the area of the tricuspid valve annulus and IVC.
Figure 2. Left-sided cryoablations are placed for patients with
preoperative atrial fibrillation around the pulmonary veins, at the
orifice of the left atrial appendage, and between the inferior
pulmonary veins and the mitral valve annulus.
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connection, will result in superior hemodynamics and an
improvement in IART management.14-20,25,26
In comparison, conversion of an atriopulmonary Fontan
to a total cavopulmonary Fontan without arrhythmia circuit
cryoablation has been shown to result in a very high level of
recurrence.14-18 Deal and colleagues,20 in 1998, reported a
comparison of patients from the same center undergoing
Fontan revision with and without concomitant cryoablation.
All patients who underwent revision alone experienced re-
current symptomatic atrial tachycardia, while the group
having cryoablation had only a 10% recurrence rate.20 Ma-
vroudis’ group19 and Deal’s group20 have impressively
mapped the areas where there is substrate for the production
of reentrant circuits in the right atrium. Their work has
followed the extensive work by Gandhi and colleagues,25,26
who in a canine model showed that surgical incisions from
the Fontan are the nidus for the arrhythmia and that inter-
ruption of these areas are necessary to effectively treat the
IART.
We believe that our experience compares favorably with
previous reports of Fontan conversion and cryoablation. In
our series, surviving patients clearly have improved hemo-
dynamics, and all but 1 patient has been relieved of the
burden of antiarrhythmic medication. This patient is well
controlled on 1 medication. We have had 2 mortalities in
this group of 10 patients. The Chicago group has seen 1
death and 3 patients go on to transplantation, suggesting a
treatment failure of 10% in their last reported series of 40
patients.17 Our higher failure rate may be due to the older
age of our patients at presentation for surgery, the small
number of patients in our series, or the inclusion of patients
with PLE.
We believe that this is the first report of Fontan conver-
sion and cryoablation being performed in patients with PLE.
One of our 2 patients with PLE did show a complete
resolution of her dependency on chronic infusion therapy.
She was in NYHA class IV before operation and improved
to NYHA class I after the procedure. Her heparin, albumin,
and intravenous immunoglobulin transfusions have been
discontinued and her last stool alpha antitrypsin level was
normal.
Although we cannot recommend Fontan conversion with
cryoablation as specific therapy for PLE, we do not feel that
the presence of PLE is a contraindication to the procedure if
arrhythmia or hemodynamic data suggest that the surgery is
indicated. Both patients with PLE had gradients from right
atrium to pulmonary artery of 2 and 3 mm Hg, which were
relieved with an extracardiac tube. The surviving patient
Figure 3. A linear and 15-mm round head cryoprobe.
Figure 4. New York Heart Association classification preopera-
tively and postoperatively.
Surgery for Congenital Heart Disease Weinstein et al
534 The Journal of Thoracic and Cardiovascular Surgery ● August 2003
CH
D
had more severe atrial arrhythmias, but both patients’ IART
was well controlled after cryoablation. The surviving pa-
tient was younger, with reasonable medical control of her
PLE, and the patient who succumbed was over 30 years old,
with severe ascites and poor compliance with medical ther-
apy for over a decade. These factors may present a variable
that relates to why 1 patient’s PLE resolved while the other
patient died of complications from the same disease.
The patient with a history of cerebral vascular accidents
and recurrent pulmonary emboli has seen significant relief
from both his recurrent pulmonary emboli and intra-atrial
reentrant tachycardia. He has not had a thromboembolic
event more than 2 years since surgery and his atrial fibril-
lation and flutter are well controlled.
We elected to perform right atrial cryoablation on every
patient, including 2 patients who did not have IART preop-
eratively. Our group feels this is the proper approach based
on Deal and colleagues’ work20 in identifying the anatomic
circuits responsible for IART in patients with APC Fontans.
Previous right atrial suture lines are resected during the
procedure and it adds little technically to perform cryoab-
lation within the right atrium. Currently, we choose not to
add left atrial cryoablation in the absence of atrial fibrilla-
tion. This requires opening the left atrium and increasing
cardiac ischemic time.
None of the patients in this series received a fenestrated
Fontan. As well, patients in whom the pulmonary artery was
still connected to the heart resulting in some percentage of
pulsatile flow did not receive a pulmonary artery discon-
nection. We believe that adult patients with a preexisting
Fontan represent a different cohort physiologically than the
typical 2- or 3-year-old child coming for a Fontan operation
today. These adult patients have already made their transi-
tion to passive pulmonary blood flow and have proven that
Fontan physiology will be tolerated. We have not seen these
adolescent and adult patients experience pulmonary vascu-
lar reactivity affecting their cardiac output. In addition, we
have found that fenestrations in extracardiac Fontans do not
stay open as long or as reliably as in a lateral tunnel Fontan.
DDD pacemakers were placed in 9 patients. Although
the Chicago group places atrial antitachycardia pacemakers
only, we were worried in our early experience that our
patients might experience atrioventricular node dysfunction.
Transvenous access for a ventricular lead after this surgery
would be difficult, and placement would require a thoracot-
omy. Currently, 2 patients are in sinus rhythm, 2 are ven-
Figure 5. These preoperative and postoperative chest radiographs represent the substantial decrease in size of the
right atrium in a 20-year-old man undergoing Fontan revision, right and left cryoablation, and right atriectomy. The
patient’s original Fontan was a common atrial–right pulmonary artery connection with a Bjo¨rk modification. This
patient had recurrent pulmonary emboli from stagnant flow in his right atria. The decrease in size of theidus
for clot formation and improved hemodynamics are well demonstrated by the change in cardiac silhouette.
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tricular sensing and atrial pacing, and 4 patients are pacing
both atria and ventricles.
We believe that this procedure is effective in improving
a patient’s symptoms of heart failure and in reducing the
recurrence of IART. Based on the improvement in NYHA
failure classification for all surviving patients, we believe
there is clinical evidence that cardiac output is improved.
Transplantation can offer a viable option in this patient
population. However, the success of pediatric cardiac trans-
plantation is equivalent to the reported results of Fontan
revision and cryoablation,17,27,28 as well as our center. In
addition, the morbidity rates of transplantation in Fontan
patients have been noted to be higher than for other sub-
groups undergoing cardiac replacement therapy.27 The mor-
bidity and mortality rates associated with immunosuppres-
sion, in addition to the limited availability of organs for
transplantation, would suggest that surgical conversion with
cryoablation is preferable in this subset of patients. This
approach results in clinically important palliation of patient
symptoms and does not preclude cardiac transplantation as
a future option. We currently offer Fontan conversion with
cryoablation for this cohort of patients before considering
transplantation.
Conclusion
We agree with previous reports that Fontan revision with
cryoablation improves the clinical outcome for patients with
IART and low cardiac output. This procedure may be an
alternative to cardiac transplantation or may act as a bridge
to transplantation. We suggest that in a patient who other-
wise meets criteria for Fontan conversion and cryoablation,
PLE may not be a contraindication to performing surgery.
Fontan conversion with cryoablation can result in improve-
ment in symptoms of PLE.
References
1. Fontan F, Mounicot FB, Baudet E, et al. “Correction” de L’Atresia
Tricuspidienne: rapport de deux cas “corriqes” par 1’utilisation d’une
technique chirurqicale nouvelle. Ann Chir Thorac Cardiovasc. 1971;
10:39-47.
2. Driscoll DJ, Offord KP, Feldt RH, et al. Five- to fifteen-year follow -
up after Fontan operation. Circulation. 1992;85:469-96.
3. Cromme-Dijkhuis AH, Hess J, Hahlen K, et al. Specific sequelae after
Fontan operation at mid- and long term follow-up. J Thorac Cardio-
vasc Surg. 1993;106:1126-32.
4. Coon PD, Rychik JR, Novelo RT, et al. Thrombus formation after the
Fontan operation. Ann Thorac Surg. 2001;71:1990-4.
5. Mertens L, Hagler DJ, Sauer U, et al. Protein losing enteropathy after
the Fontan operation: an international multicenter study. J Cardiovasc
Surg. 1998;115:1063-73.
6. Balling G, Vogt M, Kaemmerer H, et al. Intracardiac thrombus for-
mation after the Fontan operation. J Thorac Cardiovasc Surg. 2000;
119:745-52.
7. Treidman JK, Saul JP, Weindling SN, Walsh EP. Radiofrequency
ablation of intra-atrial reentrant tachycardia after surgical palliation of
congenital heart disease. Circulation. 1995;91:707-14.
8. de Leval MR, Kilner P, Gewillig M, et al. Total cavopulmonary
connection: a logical alternative to atriopulmonary connection for
complex Fontan operations. J Thorac Cardiovasc Surg. 1988;96:682-
95.
9. Balaji S, Gewillig M, Bull C, et al. Arrhythmias after the Fontan
operation. Circulation. 1991;84(Suppl III):III162-7.
10. Gentles TL, Mayer JE, Gauvreau K, et al. Fontan operation in five
hundred consecutive patients: factors influencing early and late out-
come. J Thorac Cardiovasc Surg. 1997;114:376-91.
11. Mosca RS, Kulik TJ, Goldberg CS, et al. Early results of the Fontan
procedure in one hundred consecutive patients with hypoplastic left
heart syndrome. J Thorac Cardiovasc Surg. 2000;119:1110-8.
12. Van Arsdell GS, McCrindle BW, Einarson KD, et al. Interventions
associated with minimal Fontan mortality. Ann Thorac Surg. 2000;70:
568-74.
13. Stamm C, Friehs I, Mayer JE, et al. Long-term results of the lateral
tunnel Fontan operation. J Thorac Cardiovasc Surg. 2001;121:28-41.
14. McElhinney D, Reddy VM, Moore P, et al., Revision of previous
Fontan connections to extracardiac or intraatrial conduit cavopulmo-
nary anastomosis. Ann Thorac Surg. 1996;62:1276-1283.
15. Vitullo DA, DeLeon SY, Berry TE, et al. Clinical improvement after
revision in Fontan patients. Ann Thorac Surg. 1996;61:1797-804.
16. Kreutzer J, Keane JF, Lock JE, et al. Conversion of modified Fontan
to lateral atrial tunnel cavopulmonary anastomosis. J Thorac Cardio-
vasc Surg. 1996;111:1169-76.
17. Mavroudis C, Backer CL, Deal BJ, et al. Total cavopulmonary con-
version and maze procedure for patients with failure of the Fontan
operation. J Thorac Cardiovasc Surg. 2001;122:863-71.
18. Mavroudis C, Backer CL, Deal BJ, et al. Fontan conversion to cavo-
pulmonary connection and arrhythmia circuit cryoablation. J Thorac
Cardiovasc Surg. 1998;115:547-56.
19. Mavroudis C, Deal BJ, Backer CL, Johnsrude CL. The favorable
impact of arrhythmia surgery on total cavopulmonary artery Fontan
conversion. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu.
1999;2:143-56.
20. Deal BJ, Mavroudis C, Backer CL, et al. Impact of arrhythmia circuit
cryoablation during Fontan conversion for refractory atrial tachycar-
dia. Am J Cardiol. 1999;83:563-68.
21. Balaji S, Johnson TB, Sade RM, et al. Management of atrial flutter
after the Fontan procedure. J Am Coll Cardiol. 1994;23:1209-15.
22. Kalman JM, VanHare GF, Olgin JE, et al. Ablation of incisional
reentrant atrial tachycardia complicating surgery for congenital heart
disease. Circulation. 1996;93:502-12.
23. Lesh MD, Van Hare GF, Epstein LM, et al. Radiofrequency catheter
ablation of atrial arrhythmias—results and mechanisms. Circulation.
1994;89:1074-89.
24. Kao JM, Alejos JC, Grant PW, et al. Conversion of atriopulmonary to
cavopulmonary anastomosis in management of late arrhythmias and
atrial thrombosis. Ann Thorac Surg. 1994;58:1510-4.
25. Gandhi SK, Bromberg BI, Rodefeld MD, et al. Lateral tunnel suture
line variation reduces atrial flutter after the modified Fontan operation.
Ann Thorac Surg. 1996;61:1299-309.
26. Gandhi SK, Bromberg BI, Schuessler RB, et al. Characterization and
surgical ablation of atrial flutter after the classic Fontan repair. Ann
Thorac Surg. 1996;61:1666-979.
27. Lamour JM, Addonizio LJ, Galantowicz ME, et al. Outcome after
orthotopic cardiac transplantation in adults with congenital heart dis-
ease. Circulation. 1999;100(19 Suppl):II200-5.
28. Menkis AH, McKenzie FN, Novick RJ, et al. Expanding applicability
of transplantation after multiple prior palliative procedures. Ann Tho-
rac Surg. 1991;52:722-6.
Surgery for Congenital Heart Disease Weinstein et al
536 The Journal of Thoracic and Cardiovascular Surgery ● August 2003
CH
D
